Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Self-luminescing BRET-FRET near-infrared dots for in vivo lymph-node mapping and tumour imaging.

Liqin Xiong | Adam J Shuhendler | Jianghong Rao
Nature communications | 2012

Strong autofluorescence from living tissues, and the scattering and absorption of short-wavelength light in living tissues, significantly reduce sensitivity of in vivo fluorescence imaging. These issues can be tackled by using imaging probes that emit in the near-infrared wavelength range. Here we describe self-luminescing near-infrared-emitting nanoparticles employing an energy transfer relay that integrates bioluminescence resonance energy transfer and fluorescence resonance energy transfer, enabling in vivo near-infrared imaging without external light excitation. Nanoparticles were 30-40 nm in diameter, contained no toxic metals, exhibited long circulation time and high serum stability, and produced strong near-infrared emission. Using these nanoparticles, we successfully imaged lymphatic networks and vasculature of xenografted tumours in living mice. The self-luminescing feature provided excellent tumour-to-background ratio (>100) for imaging very small tumours (2-3 mm in diameter). Our results demonstrate that these new nanoparticles are well suited to in vivo imaging applications such as lymph-node mapping and cancer imaging.

Pubmed ID: 23149738

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R21 CA138353
  • Agency: NCI NIH HHS, United States
    Id: P50CA114747
  • Agency: NCI NIH HHS, United States
    Id: U54 CA151459
  • Agency: NCI NIH HHS, United States
    Id: R01 CA135294
  • Agency: NCI NIH HHS, United States
    Id: R01CA135294
  • Agency: NCI NIH HHS, United States
    Id: U54CA119367
  • Agency: NCI NIH HHS, United States
    Id: P50 CA114747
  • Agency: NCI NIH HHS, United States
    Id: U54 CA119367
  • Agency: NCI NIH HHS, United States
    Id: R21CA138353A2

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


U-87MG ATCC (tool)

RRID:CVCL_0022

Cell line U-87MG ATCC is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions